These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36401466)

  • 1. Severe cardiotoxicity in 2 patients with thymoma receiving immune checkpoint inhibitor therapy: A case report.
    Liu S; Ma G; Wang H; Yu G; Chen J; Song W
    Medicine (Baltimore); 2022 Nov; 101(46):e31873. PubMed ID: 36401466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint inhibitor sintilimab-induced lethal myocarditis overlapping with myasthenia gravis in thymoma patient: A case report.
    Wang C; Zhong B; He J; Liao X
    Medicine (Baltimore); 2023 Apr; 102(15):e33550. PubMed ID: 37058040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal toxicity induced by anti-PD-1 immune checkpoint inhibitor in thymic epithelial tumor.
    Jing X; Zhu H; Li Y; Jia W; Zhai X; Li J; Yu J
    Immunotherapy; 2022 Oct; 14(14):1097-1107. PubMed ID: 36093721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial.
    Conforti F; Zucali PA; Pala L; Catania C; Bagnardi V; Sala I; Della Vigna P; Perrino M; Zagami P; Corti C; Stucchi S; Barberis M; Guerini-Rocco E; Di Venosa B; De Vincenzo F; Cordua N; Santoro A; Giaccone G; De Pas TM
    Lancet Oncol; 2022 Oct; 23(10):1287-1296. PubMed ID: 36096156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune checkpoint inhibitor-induced myocarditis with myasthenia gravis overlap syndrome: A case report and literature review.
    Gao L; Li X; Guo Z; Tang L; Peng J; Liu B
    Medicine (Baltimore); 2022 Dec; 101(49):e32240. PubMed ID: 36626474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor.
    Luciano A; Pietroluongo E; Ottaviano M; Grieco A; Peddio A; De Placido P; Servetto A; Mascolo M; Varricchio S; Bianco R; Palmieri G; Giuliano M
    Front Immunol; 2024; 15():1423800. PubMed ID: 39026684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-Therapy-Related Toxicity Events and Dramatic Remission After a Single Dose of Pembrolizumab Treatment in Metastatic Thymoma: A Case Report.
    Shen L; Chen H; Wei Q
    Front Immunol; 2021; 12():621858. PubMed ID: 33936037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors.
    Arangalage D; Degrauwe N; Michielin O; Monney P; Özdemir BC
    Cancer Treat Rev; 2021 Nov; 100():102282. PubMed ID: 34438238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity.
    Zarifa A; Lopez-Mattei J; Palaskas NL; Iliescu C; Durand JB; Kim PY
    Adv Exp Med Biol; 2021; 1342():377-387. PubMed ID: 34972975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune checkpoint inhibitor myocarditis in thymic epithelial tumors: a case report and literature review.
    Feng Y; Zheng P; Zhang W; Yang S; You Y; Chen Y; Ye Y
    Transl Cancer Res; 2024 Feb; 13(2):1208-1218. PubMed ID: 38482422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study.
    Xie X; Wang L; Li Y; Xu Y; Wu J; Lin X; Lin W; Mai Q; Chen Z; Zhang J; Xie Z; Qin Y; Liu M; Lu M; Luo B; Zhou C
    Front Immunol; 2022; 13():879900. PubMed ID: 35924238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity of Immune Checkpoint Inhibitors.
    Patel RP; Parikh R; Gunturu KS; Tariq RZ; Dani SS; Ganatra S; Nohria A
    Curr Oncol Rep; 2021 May; 23(7):79. PubMed ID: 33937956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiotoxicity of immune checkpoint inhibitors: A frequency network meta-analysis.
    Liu M; Cheng X; Ni R; Zheng B; Huang S; Yang J
    Front Immunol; 2022; 13():1006860. PubMed ID: 36189211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of subclinical immune checkpoint inhibitor-associated myocarditis in non-small cell lung cancer.
    Hu Y; Liu C; Jin S; Yi Z; Wang C; Pan X; Huang H
    BMC Pulm Med; 2023 Apr; 23(1):119. PubMed ID: 37060029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Potential of Docetaxel plus Cisplatin Chemotherapy for Myasthenia Gravis Patients with Metastatic Thymoma.
    Qi G; Liu P; Dong H; Gu S; Yang H; Xue Y
    Tohoku J Exp Med; 2017 Apr; 241(4):281-286. PubMed ID: 28381664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study.
    Wang W; Lin G; Hao Y; Guan Y; Zhang Y; Xu C; Wang Q; Wang D; Jiang Z; Cai J; Lou G; Song Z; Zhang Y
    Eur J Cancer; 2022 Oct; 174():21-30. PubMed ID: 35970032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the landscape of immunotherapy in thymic epithelial tumors.
    Maniar R; Loehrer PJ
    Cancer; 2023 Apr; 129(8):1162-1172. PubMed ID: 36808725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocarditis related to immune checkpoint inhibitors treatment: two case reports and literature review.
    Chen Y; Jia Y; Liu Q; Shen Y; Zhu H; Dong X; Huang J; Lu J; Yin Q
    Ann Palliat Med; 2021 Jul; 10(7):8512-8517. PubMed ID: 34263614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal myocarditis and rhabdomyolysis induced by nivolumab during the treatment of type B3 thymoma.
    Chen Q; Huang DS; Zhang LW; Li YQ; Wang HW; Liu HB
    Clin Toxicol (Phila); 2018 Jul; 56(7):667-671. PubMed ID: 29126352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research Progress of Immune Checkpoint Inhibitor-associated Myocarditis].
    Liu Y; Chen Y; Zeng Z; Liu A
    Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):668-672. PubMed ID: 34521189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.